Tobramycin/Vancomycin (Sonoran Biosciences)

妥布霉素/万古霉素 （Sonoran Biosciences）

Report date: 2025/12/26 16:03:44

Base Information

Drug NameTobramycin/Vancomycin (Sonoran Biosciences)
Drug Alias NameSBG-002
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of Action30S ribosomal subunit inhibitorsCell wall inhibitorsPeptidoglycan inhibitors
Targets30S ribosomal subunitPeptidoglycan
Therapy Area/IndicationsBacterial Infections and Mycoses
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsYes
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSonoran Biosciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesSonoran Biosciences Inc
Inactive CompaniesN/A
Active IndicationsBacterial Infections and Mycoses
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A